Merck & Co (MRK) Financials
Merck & Co (MRK) Historical Financial Statements and Key Metrics for 1990 - 2020
Full Merck & Co financials for 1990 - 2020 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Merck & Co Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2020-Dec-31 | 501 | 386 (77.0 %) | 0 (0.0 %) | 0 (0.0 %) | -822 | 0.00 |
| 2020-Sep-30 | 12,551 | 9,070 (72.3 %) | 3,230 (27.3 %) | 2,941 (23.4 %) | 4,247 | 1.16 |
| 2020-Jun-30 | 10,872 | 7,713 (70.9 %) | 3,212 (32.4 %) | 3,002 (27.6 %) | 4,332 | 1.18 |
| 2020-Mar-31 | 12,057 | 8,813 (73.1 %) | 3,909 (32.4 %) | 3,219 (26.7 %) | 4,871 | 1.26 |
| 2019-Dec-31 | 11,868 | 8,994 (75.8 %) | 2,568 (21.6 %) | 2,356 (19.9 %) | 3,889 | 0.92 |
| 2019-Sep-30 | 12,397 | 8,469 (68.3 %) | 2,382 (19.2 %) | 1,901 (15.3 %) | 3,418 | 0.74 |
| 2019-Jun-30 | 11,760 | 8,424 (71.6 %) | 3,399 (28.9 %) | 2,670 (22.7 %) | 4,491 | 1.03 |
Full historical income statements for 1990 - 2020 is included in the
US Historical Financials dataset.
Merck & Co Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2020-Dec-31 | 62,606 | 0 | 31,791 | 25,317 | 8,847 |
| 2020-Sep-30 | 89,800 | 60,530 | 28,741 | 29,186 | 7,356 |
| 2020-Jun-30 | 90,615 | 62,871 | 30,874 | 27,642 | 11,103 |
| 2020-Mar-31 | 84,913 | 58,708 | 27,998 | 26,205 | 7,432 |
| 2019-Dec-31 | 84,397 | 58,490 | 26,346 | 25,907 | 10,450 |
| 2019-Sep-30 | 83,331 | 56,493 | 26,088 | 26,838 | 8,018 |
| 2019-Jun-30 | 83,965 | 56,330 | 26,587 | 27,635 | 7,105 |
Full historical balance sheet data for 1990 - 2020 is included in the
US Historical Financials dataset.
Merck & Co Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2020-Dec-31 | 4,006 | -9,443 | -2,832 | 7,176 |
| 2020-Sep-30 | 2,173 | 0 | 0 | 657 |
| 2020-Jun-30 | 3,367 | 0 | 0 | 2,699 |
| 2020-Mar-31 | 707 | -1,628 | -1,490 | -279 |
| 2019-Dec-31 | 4,794 | -763 | -2,011 | 3,657 |
| 2019-Sep-30 | 4,226 | 191 | -3,152 | 3,267 |
| 2019-Jun-30 | 3,084 | -2,425 | -2,084 | 2,302 |
Full historical cash flow data for 1990 - 2020 is included in the
US Historical Financials dataset.
Merck & Co Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2020-Dec-31 | 206,934 | 230,663 | 413.04 | 0.00 | 8.17 |
| 2020-Sep-30 | 209,844 | 228,809 | 16.72 | 71.35 | 7.19 |
| 2020-Jun-30 | 195,413 | 210,466 | 17.97 | 65.09 | 7.07 |
| 2020-Mar-31 | 194,421 | 208,633 | 16.13 | 60.40 | 7.42 |
| 2019-Dec-31 | 229,014 | 242,074 | 19.30 | 97.20 | 8.84 |
| 2019-Sep-30 | 211,593 | 226,401 | 17.07 | 111.31 | 7.88 |
| 2019-Jun-30 | 212,935 | 229,047 | 18.11 | 79.75 | 7.71 |
Full historical valuation and operating metrics for 1990 - 2020 are included in the
US Historical Financials dataset.